(Q28565750)

31 January 2017

title

Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis (English)

1 reference

31 January 2017

0 references

Thyyar M. Ravindranath

1

1 reference

31 January 2017

Masakatsu Goto

2

1 reference

31 January 2017

Omer Iqbal

3

1 reference

31 January 2017

Michelle Florian-Kujawski

4

1 reference

31 January 2017

Debra Hoppensteadt

5

1 reference

31 January 2017

Rashid Hammadeh

6

1 reference

31 January 2017

Mohammad M. Sayeed

7

1 reference

31 January 2017

J. Fareed

8

1 reference

31 January 2017

language of work or name

1 reference

1 October 2007

1 reference

Clinical and Applied Thrombosis-Hemostasis

31 January 2017

published in

1 reference

31 January 2017

volume

13

1 reference

31 January 2017

issue

4

1 reference

31 January 2017

page(s)

362–368

1 reference

Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

Relationship between the inflammation and coagulation pathways in patients with severe sepsis: implications for therapy with activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

The rediscovery and isolation of TFPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

Pathophysiology of disseminated intravascular coagulation in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

Absence of procarboxypeptidase R induces complement-mediated lethal inflammation in lipopolysaccharide-primed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

The endothelium in sepsis: source of and a target for inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607305580

21 January 2018

Identifiers

DOI

10.1177/1076029607305580

1 reference

31 January 2017

1 reference